Press release
Cancer Biomarkers Market Size ,Growth Research Report 2024-2032 | 250 Pages
Cancer Biomarkers Market
Cancer biomarkers are biological molecules that can be used to diagnose, monitor, and predict the course of cancer. They play a crucial role in personalized medicine, allowing for targeted therapies and improved patient outcomes. The cancer biomarkers market encompasses various products and services, including instruments, consumables, and bioinformatics software.
Get free copy of the Cancer Biomarkers Market report 2024: https://www.reportsanddata.com/download-free-sample/1422
Key Trends Shaping the Market
Rising Focus on Early Detection: Early detection of cancer significantly improves prognosis and treatment success rates. Biomarkers offer a non-invasive or minimally invasive approach to early cancer detection, driving market growth.
Growing Adoption of Companion Diagnostics: Companion diagnostics are biomarker tests used to identify patients who are most likely to benefit from specific targeted therapies. This personalized medicine approach is propelling the demand for cancer biomarkers.
Technological Advancements: Continuous advancements in technologies like next-generation sequencing (NGS) and liquid biopsies are revolutionizing cancer diagnosis and treatment. These innovations are expected to create new avenues for biomarker development and market expansion.
Drivers and Restraints
Drivers:
Increasing cancer burden worldwide
Growing geriatric population
Rising healthcare expenditure
Technological advancements in biomarker discovery and development
Growing awareness about cancer screening and early detection
Restraints:
Stringent regulatory processes for biomarker approval
High cost of biomarker tests
Reimbursement challenges
Access full Report Description, TOC, Table of Figure, Chart, etc. @ https://www.reportsanddata.com/report-detail/cancer-biomarkers-market
Growth Opportunities
Development of multiplex biomarker assays for a broader range of cancer types
Integration of artificial intelligence (AI) and machine learning for biomarker analysis
Expansion into emerging markets with growing healthcare infrastructure
Rising focus on personalized medicine and targeted therapies
SWOT Analysis
Strengths:
Growing demand for early cancer detection
Technological advancements in biomarker discovery
Increasing adoption of companion diagnostics
Weaknesses:
High cost of biomarker tests
Stringent regulatory processes
Limited availability of skilled personnel
Opportunities:
Development of novel biomarker assays
Expansion into emerging markets
Integration of AI and machine learning for data analysis
Threats:
Reimbursement challenges
Stringent regulatory landscape
Competition from generic biomarker tests
Latest Strategic Developments :
On 3 March 2020, Thermo Fisher Scientific Inc. announced the acquisition of QIAGEN N.V. for approximately USD 11.5 billion. The acquisition was aimed at expanding Thermo Fisher's presence in the molecular diagnostics market and strengthening its position in the life sciences industry.
On 18 August 2021, Illumina, Inc. announced the acquisition of GRAIL, a company developing a blood test for early cancer detection. The acquisition was valued at approximately USD 8 billion and aimed to accelerate the development of a non-invasive cancer screening test.
On 20 November 2019, Bristol-Myers Squibb Company announced the acquisition of Celgene Corporation for approximately USD 74 billion. The acquisition was aimed at expanding Bristol-Myers Squibb's product offerings in the oncology market and strengthening its position as a leader in the industry.
Key Market Insights
Based on type, the global cancer biomarkers market is segmented into protein biomarkers, genetic biomarkers, and others. The protein biomarkers segment accounted for largest revenue share in 2022. Rising prevalence of cancer and the expanding use of protein-based tests for cancer detection and therapy are the main factors driving revenue growth of the segment. Prostate-Specific Antigen (PSA), Carcinoembryonic Antigen (CEA), and Cancer Antigen 125 (CA-125) are just a few of the proteins that are frequently used to detect cancer, track the effectiveness of treatment, and forecast patient outcomes. Revenue growth of the segment is being further driven by availability of innovative protein detection technologies such as mass spectrometry and protein microarrays.
Based on type, the global cancer biomarkers market is segmented into diagnosis, prognosis, and treatment. The diagnosis segment accounted for largest revenue share in 2022. Rising prevalence of cancer and the expanding use of biomarker-based tests for cancer screening and early detection are the main factors driving revenue growth of the segment. The development of new biomarkers and detection technologies is further driving revenue growth of the segment. Biomarkers such as PSA, CA-125, and human Chorionic Gonadotropin (hCG) are frequently utilized for cancer diagnosis.
The market in North America accounted for largest revenue share in 2022. The region has a well-established healthcare infrastructure and excellent research and development capabilities, which have considerably contributed to revenue growth of the cancer biomarkers market. Revenue growth of the market is driven by rising prevalence of cancer and public awareness of early cancer detection. Also, the region has seen the rise of numerous Biotechnology and pharmaceutical firms, who have actively invested in the study and development of cancer biomarkers, driving revenue growth of the market. The U.S. dominates the market in North America due to rising government initiatives, such as funding for cancer research and development, and advantageous reimbursement rules for cancer biomarker testing.
Access Sample Copy @ https://www.reportsanddata.com/download-free-sample/1422
Some of the major companies operating in the global Cancer Biomarkers market include:
F. Hoffmann-La Roche Ltd.
QIAGEN N.V.
Thermo Fisher Scientific Inc.
Illumina, Inc.
Bristol-Myers Squibb Company
Becton, Dickinson and Company
Novartis AG
Bio-Rad Laboratories, Inc.
Abbott Laboratories
Siemens Healthineers AG
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Biomarkers Market Size ,Growth Research Report 2024-2032 | 250 Pages here
News-ID: 3559108 • Views: …
More Releases from Reports And Data
Forensic Technology Market Size ,Growth Research Report 2024-2032 | 250 Pages
The global forensic technology market is forecast to reach a market size of USD 50.41 Billion by 2027 and register a rapid revenue growth rate over the next seven years, according to a new report by Reports and Data. The forensic technology market continues to register major growth owing to increasing demand and usage of advanced technologies to solve crimes. High demand for these solutions is also due to upsurge…
Folinic Acid Market Size ,Growth Research Report 2024-2026 | 250 Pages
The global Folinic acid industry is projected to undergo a steady growth in the forecasted years as observed by the outcome of the analysis provided in this study. The report encompasses the different factors that have a substantial impact on revenue of the businesses. This study also profiles the key players that account for a significant share in the global economy of the Folinic acid business. The key players have…
Crizotinib Market Size ,Growth Research Report 2024-2026 | 250 Pages
This Crizotinib market research provides a comprehensive study of the industry's size, share, demand, growth, gross profits, earnings, and sales. It analyzes the data acquired to provide a comprehensive perspective of industry trends and forecasts probable developments throughout the anticipated time period. For this study, historical data from 2016 and 2017 was collected, with 2018 serving as the base year to forecast the industry's growth from 2019 to 2026.
The global…
Palbociclib Market Size ,Growth Research Report 2024-2026 | 250 Pages
The global Palbociclib industry is expected to grow steadily in the upcoming years. Asia Pacific is anticipated to expand at the fastest CAGR of 12% during the forecast period. The other geographical regions covered in this study are Europe, North America, Latin America, Middle East and Africa. The key players in the Palbociclib drug businesses are Pfizer, Beacon Pharmaceuticals, Incepta Pharmaceuticals, Bluepharma, NANO DARU, among others. The data here offers…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
Oncology Nutrition Market led to an unprecedented rise by 2025 : liver cancer, p …
Global Oncology Nutrition Market: Overview
Cancer diagnosis creates myriad questions about diet and nutrition. Those pertain to if the food will make a patient feel sick to what should be ingested to fight cancer. This has spawned the oncology nutrition market which has been rising steadily due to the increasing cases of different types of cancer worldwide. During cancer treatment one needs to eat right in order to build up strength…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports.
This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.
This report focuses on top…
